Entry

Score

Action

Category / Wining Level

Final Score

Validated Score

Judging Score

Published

Information Technology - Health Products & Services
(Platinum Winner)

PO#

#TBA03877

Payment Status

Paid

PO Created Date

2025-01-07 03:01:21

Paid Date

2025-01-07 03:03:25

Competition

2025

Season

Entry ID

TBE104263

Entry Submission Date

2025-01-05 20:52:58

Member's Name

Karthik Akinapelli

Member's Email

akinapellikarthik11@gmail.com

Entry Level

Others

Results Publish

Published

Private Entry

Yes

Hide Entry

Yes

Review

Entry Status

Category

View Entry Info

IT25054 - Health Products & Services

Title

Company

Entrepreneur/ Executive’s Name

Submission Type

Country

Client

Linkedin Profile Link

Project Description

Project Description for Judges

Question 1 : Provide a brief description / background of your nominated organizational, departmental, team, or individual circumstance. (Your response to this question will be used for public display if your entry is awarded.)

Description: Karthik Akinapelli is a distinguished healthcare technology leader with extensive expertise in developing groundbreaking therapeutic solutions for critical infectious diseases. His profound impact on the healthcare industry is demonstrated through his leadership in advancing innovative treatments that address urgent medical needs. As a Lead Statistical Programmer, he has played a pivotal role in transforming patient care through data-driven approaches and regulatory excellence. His work has been instrumental in bringing revolutionary treatments to market, particularly in the realm of antibiotic resistance and infectious disease management.
Background: Karthik's technical acumen and strategic oversight have been fundamental in shepherding critical pharmaceutical innovations through complex regulatory pathways. His expertise in ORLYNVAH's development stands as a testament to his ability to navigate intricate clinical trials while maintaining exceptional data integrity. Karthik has demonstrated remarkable proficiency in managing both inhouse operations and external collaborations, ensuring seamless integration of diverse healthcare technologies and methodologies. His work spans the entire spectrum of drug development, from initial clinical trials to successful regulatory submissions.
His notable achievements include:
Led the statistical programming for breakthrough therapies targeting an estimated market of 30 million annual cases in the urinary tract infection space
Orchestrated comprehensive data analysis that contributed to products achieving a 40% compound annual growth rate and generating $180 million in global sales
Spearheaded the development of innovative therapeutic solutions that revolutionized treatment paradigms, particularly in outpatient and ambulatory care settings
Under Karthik's leadership, these initiatives have significantly improved patient outcomes by reducing hospitalization requirements and enhancing treatment compliance through innovative oral administration methods. His expertise in developing data-driven solutions has been crucial in addressing the escalating concerns of antibiotic resistance in healthcare systems, ultimately contributing to more efficient and cost-effective treatment approaches. His work continues to shape the future of infectious disease management through the development of accessible and effective therapeutic options.

Question 2 : Outline your nominated organizational, departmental, team, or individual achievements, dated 1-3 years prior, based on your selected categories.

Professional Achievements: Karthik Akinapelli has demonstrated exceptional leadership in advancing breakthrough therapeutics for critical infectious diseases. As a Lead Statistical Programmer, his pivotal role in the development of ORLYNVAH exemplifies his ability to drive innovation in healthcare solutions. His expertise in managing complex clinical trials and regulatory submissions has resulted in successful FDA approvals for novel treatments. Karthik's strategic oversight of data validation and analysis has been instrumental in establishing new standards for antibiotic therapy, particularly in addressing drug-resistant pathogens.
Clinical Impact: His contributions to DALVANCE's development showcased his proficiency in steering sophisticated clinical programs. Through his meticulous approach to data integrity and regulatory compliance, Karthik successfully supported critical FDA Advisory Committee meetings, leading to groundbreaking therapeutic approvals. His leadership in statistical programming has directly influenced the advancement of treatments reaching an estimated 30 million annual cases in the urinary tract infection therapeutic space.
Key Achievements:
Led comprehensive programming efforts resulting in products achieving 40% compound annual growth rate and generating $180 million in global sales
Spearheaded the development of innovative therapeutic solutions that transformed treatment paradigms in outpatient care
Orchestrated data validation processes that ensured successful regulatory submissions and approvals for multiple breakthrough medications
Industry Recognition: Karthik's expertise in developing data-driven healthcare solutions has significantly impacted patient care by reducing hospitalization requirements and enhancing treatment compliance. His work in advancing oral therapeutic options has addressed critical gaps in antibiotic resistance management, particularly in outpatient settings. His leadership in statistical programming and data analysis has been fundamental in establishing new standards for clinical trial execution and regulatory submissions in the pharmaceutical industry.
Technical Excellence: As an accomplished healthcare technology innovator, Karthik has consistently demonstrated superior capabilities in managing complex data analysis systems. His expertise extends to supporting FDA Information Requests, ensuring seamless regulatory reviews, and maintaining stringent quality standards throughout the development process. His collaborative approach with clinicians and data management teams has established robust frameworks for ensuring data integrity and analytical excellence in therapeutic development programs.

Question 3 : Provide examples of the strategies / plans you have introduced, in order to attain your nominated organizational, departmental, team, or individual achievements. Explain why the highlighted achievements are significant / unique.

Strategic Leadership Approach: Karthik's methodical approach to healthcare innovation centers on leading inhouse programming efforts while overseeing datasets development through external vendors. His strategic framework encompasses comprehensive oversight of both SDTM and ADAM datasets, ensuring seamless integration for Clinical Study Reports. Through ORLYNVAH's development, he implemented a robust system of coordinating with multiple departments, establishing a foundation for successful FDA submission leading to approval of the drug.
Data Integrity Protocol: His distinctive methodology focuses on maintaining stringent quality assurance protocols through systematic data validation. This approach proved crucial during the development of treatments targeting an estimated 30 million annual cases of urinary tract infections. Karthik's framework emphasizes thorough validation of endpoint derivation and double programming of critical components, ensuring compliance with regulatory standards.
Regulatory Excellence Framework: In steering products to achieve $180 million in global sales and a 40% compound annual growth rate, Karthik developed a comprehensive strategy for managing FDA Information Requests. His approach integrated rapid response protocols with detailed analytical support, facilitating seamless regulatory approvals.
Achievement Significance: The uniqueness of Karthik's contributions lies in his innovative approach to developing oral therapeutic solutions for drug-resistant pathogens. His work transformed traditional treatment paradigms by:
Pioneering data-driven methodologies that revolutionized outpatient care protocols
Establishing new standards for clinical trial execution through advanced statistical programming
Creating frameworks that significantly reduced hospitalization requirements while improving treatment compliance
Implementation Impact: Karthik's strategic initiatives have been particularly significant in addressing critical gaps in antibiotic therapy. His methodological approach to DALVANCE's development demonstrated exceptional efficacy in managing complex clinical trials, while his innovative data management strategies established new benchmarks in pharmaceutical development. These achievements showcase his ability to implement transformative solutions that advance healthcare technology while maintaining regulatory compliance.
Quality Management Innovation: Karthik's strategic vision extended to developing comprehensive quality management systems that ensured data reliability throughout the development lifecycle. His innovative approach to coordinating with clinicians and data management teams established new paradigms for maintaining data integrity. This systematic methodology proved instrumental in achieving successful regulatory submissions and approvals, demonstrating his capability to drive excellence in therapeutic development.

Optional Context for Judges (Not for publication. This section is solely for judges' evaluation.)

Thumbnail

Cancel

Link List

Link	Password Protected	Display (Winner Info)
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-new-treatment-uncomplicated-urinary-tract-infections-adult-women-who-have-limited-or-no	No	Display
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshot-dalvance-dalbavancin	No	Display
https://www.pharmacytimes.com/view/dalvance-by-durata-therapeutics	No	Display

Credit List

Actions	Name	Title Organization

File List

Remove	Actions	File Link	File Size	File Link (System Resize)	File Size (System Resize)	Display(Winner Page)	Display Check
		upload/entry/files/TBE104263/1745495475file_9157.jpg	115.34KB	upload/entry/files/TBE104263/1745495475file_9157.jpg	115.34KB	Display

Activity Logs

Action	Details	Performed By	IP Address	Date

Edit Entry

Score

Link List

Credit List

File List

Activity Logs